Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 7, 2025 -- For children with obstructive sleep apnea (OSA) with nocturnal enuresis (NE), the remission rate of NE is more than half for those undergoing adenoidectomy and/or tonsillectomy, according to a review published online Jan. 25 in the European Archives of Oto-Rhino-Laryngology.
Zhe Wang, from the General Hospital of Northern Theater Command in Shenyang, China, and colleagues conducted a systematic review to examine the efficacy of tonsillectomy and/or adenoidectomy for the treatment of NE in children with OSA.
The researchers found that for children with NE who underwent adenoidectomy and/or tonsillectomy, the combined overall remission (OR), complete remission (CR), and partial remission rates were 67, 57, and 4 percent, respectively. The pooled OR and CR for primary NE were 67 and 59 percent, respectively, in children with OSA. For children treated with adenotonsillectomy, the pooled OR was 72 percent, while the CR was 65 percent. For children older than 5 years with OSA, the pooled OR and CR were 67 and 58 percent, respectively. For postoperative follow-up of no more than three months, the pooled OR and CR were 64 and 52 percent, respectively. Based on randomized controlled trials, the pooled OR and CR of NE were both 37.3 percent.
"We should be relatively cautious in interpreting these results and the actual remission rate may be lower than we expected," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
FRIDAY, July 11, 2025 -- Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients diagnosed with pancreatic cancer...
Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
WEDNESDAY, July 9, 2025 -- Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization...
A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization
MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.